Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tobacco Biomarkers Detected in Smokers' Breath

By LabMedica International staff writers
Posted on 01 Jun 2010
A device analyzes individuals' breath samples to determine whether they had smoked during the previous three days.

Scientists designed an apparatus to analyze 0.8-L breath samples, whereas commercial analyzers require 2 L. More...
The device utilized an adsorption microtrap, which could release fluid in less than one second during the phase of desorption and did not require a second cryogenic trap.

A chemical compound in the breath of smokers indicated that they had smoked within the last three days. The chemical is not present in nonsmokers' breath unless they have been in contact with tobacco smoke for extended periods of time. Biomarkers of exposure are chemicals found in the body providing evidence of environmental exposure to that chemical or to a precursor chemical.

Breath samples from 100 smokers and 104 nonsmokers were analyzed by scientists at the University of Girona, (UdG; Gerona, Spain). The study participants, 147 females and 57 males, aged between 16 to 53 years, were also questioned about their lifestyle. The levels of benzene, 2,5-dimethylfuran, toluene, o-xylene, and m-p-xylene were measured using a new micro-trap system coupled with gas chromatography–mass spectrometry.

Benzene was only an effective biomarker for medium and heavy smokers, and its level was affected by smoking habits. The volatile organic compound 2,5-dimethylfurane was the only chemical found in smokers' breath 72 hours after they had inhaled tobacco smoke independent of smoking habits, such as short or long term exposure, light or heavy consumption. The scientists were able to detect 2,5-dimethylfuran in 12 breath samples of nonsmokers, who when questioned more thoroughly, were in fact social or weekend smokers.

Juan Manuel Sánchez Ph.D., of the chemistry department, UdG, stated that the method would be particularly useful to assess tobacco-related exposure in patients who do not admit to smoking or minimize their intake to their physicians. Smoking is well known risk factor for several pathological conditions including vascular and lung diseases.

The study was published online in February 2010 in Analytical and Bioanalytical Chemistry. The investigation is continuing and the technique is undergoing further development and improvement.

Related Links:

University of Girona




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.